Hexavalent Influenza mRNA Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Hexavalent Influenza mRNA Vaccine, covering 2025-05-30 to 2025-05-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older [Phase 1, Phase 2]